Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new xatral clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on xatral
- Alfuzosin Treatment in Children and Adolescents With Hydronephrosis of Neuropathic Etiology
Status: Recruiting, Condition Summary: Hydronephrosis; Neurogenic Bladder - Does Treatment With Alfuzosin Increase Success Rates of (SWL) Shock Wave Lithotripsy
Status: Recruiting, Condition Summary: Urolithiasis; Nephrolithiasis; Ureterolithiasis - Randomized Trial Comparing Alfuzosin GITS 10 mg Daily With Placebo for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up
Status: Terminated, Condition Summary: Prostatic Hyperplasia; Urinary Retention; Acute Disease - The Long Term Effects of Alfuzosin(Xatral XL) in LUTS/BPH Patients: Evaluation of Voiding and Storage Function
Status: Active, not recruiting, Condition Summary: BPH - Clinical Trial in Males With BPH (Enlarged Prostate)
Status: Completed, Condition Summary: Urinary Retention; Prostatic Hyperplasia; Benign Prostatic Hypertrophy - Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS)
Status: Recruiting, Condition Summary: Multiple Sclerosis; Bladder Dysfunction - The Clinical Efficacy of Non-Steroidal Anti-Inflammation Drugs in Patients With Benign Prostatic Hyperplasia
Status: Not yet recruiting, Condition Summary: Benign Prostatic Hyperplasia - Efficacy and Safety of Alfuzosin for the Treatment of Voiding Dysfunction in Female: A 8 Week Prospective, Randomized, Double Blind, Placebo-Controlled, Parallel Group Study (Phase Ⅱ)
Status: Not yet recruiting, Condition Summary: Female Voiding Dysfunction - Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality Study
Status: Completed, Condition Summary: Prostatic Diseases - SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin
Status: Completed, Condition Summary: Prostatic Hyperplasia - Once Daily Given Alfuzosin in the Treatment of BPH
Status: Completed, Condition Summary: Benign Prostatic Hyperplasia - Alfuzosin for Treating Acute Urinary Retention
Status: Completed, Condition Summary: Acute Urinary Retention - Trial to Compare Alfuzosin Versus Placebo in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Completed, Condition Summary: Prostatitis - Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic Etiology
Status: Completed, Condition Summary: Urinary Bladder, Neurogenic - Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi
Status: Completed, Condition Summary: Kidney Calculi; Ureteral Calculi; Colic - Alfuzosin Hydrochloride to Relieve Ureteral Stent Discomfort
Status: Completed, Condition Summary: Ureteral Stent Discomfort - ALF-ONE : ALFuzosin ONcE Daily
Status: Completed, Condition Summary: Prostatic Hyperplasia - Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH
Status: Completed, Condition Summary: Benign Prostatic Hyperplasia - Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia
Status: Completed, Condition Summary: Prostatic Hyperplasia - Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder Dysfunction
Status: Recruiting, Condition Summary: Neurogenic Urinary Bladder - A Randomized Study of Whether Alfuzosin(Xatral) Helps in the Passage of Kidney Stones
Status: Recruiting, Condition Summary: Kidney Stones - Minimally Invasive Surgical Therapy for BPH
Status: Terminated, Condition Summary: Benign Prostatic Hyperplasia - Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study
Status: Completed, Condition Summary: Prostatic Hyperplasia - Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED)
Status: Recruiting, Condition Summary: BPH; Erectile Dysfunction - SAMBA-Thailand: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin
Status: Active, not recruiting, Condition Summary: Prostatic Hyperplasia - Multicenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL®) in Patients With Benign Prostate Hypertrophy
Status: Completed, Condition Summary: BPH/LUTS/Sexual Functions - The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score
Status: Completed, Condition Summary: Benign Prostatic Hyperplasia - Use of Alfuzosin in Stone Treatment With ESWL
Status: Recruiting, Condition Summary: Urinary Calculi - ALF-STONE: Alfuzosin in Uretheric Stones
Status: Terminated, Condition Summary: Prostatic Hyperplasia - Alfuzosin Versus Placebo in Acute Urinary Retention
Status: Terminated, Condition Summary: Urinary Retention